LAUSANNE, Switzerland (AP) — LAUSANNE, Switzerland (AP) — AC Immune SA (ACIU) on Tuesday reported third-quarter net income of $6.4 million, after reporting a loss in the same period a year earlier.
The Lausanne, Switzerland-based company said it had net income of 6 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.
The biopharmaceutical company posted revenue of $29.4 million in the period.
The company's shares closed at $2.95. A year ago, they were trading at $2.83.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACIU at https://www.zacks.com/ap/ACIU
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。